20 Chapter 1 References 1. Cohen PJ. Oxygen and intracellular metabolism. International anesthesiology clinics 1981;19(3):9-19. 2. Schittny JC. Development of the lung. Cell and tissue research 2017;367(3):427-44. 3. Mathias M, Chang J, Perez M, et al. Supplemental Oxygen in the Newborn: Historical Perspective and Current Trends. Antioxidants (Basel, Switzerland) 2021;10(12) 4. Ogihara T, Hirano K, Morinobu T, et al. Raised concentrations of aldehyde lipid peroxidation products in premature infants with chronic lung disease. Archives of disease in childhood Fetal and neonatal edition 1999;80(1):F21-5. 5. Warner BB, Stuart LA, Papes RA, et al. Functional and pathological effects of prolonged hyperoxia in neonatal mice. The American journal of physiology 1998;275(1):L110-7. 6. Giannone PJ, Bauer JA, Schanbacher BL, et al. Effects of hyperoxia on postnatal intestinal development. Biotechnic & histochemistry : official publication of the Biological Stain Commission 2007;82(1):17-22. 7. Liu Y, Jiang P, Du M, et al. Hyperoxia-induced immature brain injury through the TLR4 signaling pathway in newborn mice. Brain research 2015;1610:51-60. 8. Kennedy C, Grave GD, Sokoloff L. Alterations of local cerebral blood flow due to exposure of newborn puppies to 80-90 per cent oxygen. European neurology 1971;6(1):137-40. 9. Silverman WA. Retrolental Fibroplasia: A Modern Parable. New York, New York: Grune & Stratton, Inc. 1980. 10. Hellström A, Hård AL. Screening and novel therapies for retinopathy of prematurity - A review. Early human development 2019;138:104846. 11. Di Fiore JM, Bloom JN, Orge F, et al. A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity. J Pediatr 2010;157(1):6973. 12. Martin RJ, Wang K, Koroglu O, et al. Intermittent hypoxic episodes in preterm infants: do they matter? Neonatology 2011;100(3):303-10. 13. Imanishi Y, Hirata K, Nozaki M, et al. Effect of fluctuation of oxygenation on the development of severe retinopathy of prematurity in extremely preterm infants. J Perinatol 2020;40(3):515-21. 14. Trzcionkowska K, Vehmeijer W, Kerkhoff FT, et al. Increase in treatment of retinopathy of prematurity in the Netherlands from 2010 to 2017. Acta ophthalmologica 2021;99(1):97103. 15. Blencowe H, Lawn JE, Vazquez T, et al. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatric research 2013;74(1):35-49. 16. Alvira CM, Morty RE. Can We Understand the Pathobiology of Bronchopulmonary Dysplasia? The Journal of pediatrics 2017;190:27-37. 17. Mourani PM, Abman SH. Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond. Curr Opin Pediatr 2013;25(3):329-37. 18. Thibeault DW, Mabry SM, Ekekezie, II, et al. Lung elastic tissue maturation and perturbations during the evolution of chronic lung disease. Pediatrics 2000;106(6):14529. 19. Stoll BJ, Hansen NI, Bell EF, et al. Neonatal outcomes of extremely preterm infants from
RkJQdWJsaXNoZXIy MTk4NDMw